YOUNGHEARTVALVE INC

Next-generation polymeric TAVR technology inspired by nature

WILMINGTON, United States · Founded 2021 · $2.8M raised

Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$2.8M
Last Round
$2.8M GrantOct 2024
Rounds
1

About

YoungHeartValve is a medical device company developing a next-generation polymeric transcatheter aortic valve (TAVR) that integrates hyaluronan into polymer leaflets to resist thrombosis and calcification without animal-derived tissue. Their fully synthetic, tissue-free valve platform enables scalable, automated manufacturing and has demonstrated biocompatibility in pre-clinical animal studies. The company has received NIH SBIR grants and holds multiple patents.

Summary

YOUNGHEARTVALVE INC is a Biotech company based in WILMINGTON, United States, founded in 2021. It has raised $2.8M in total across 1 round, most recently a $2.8M Grant round in Oct 2024. Investors include NIH.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

GrantOct 2024
$2.8M

Investors

Similar Companies